These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1378145)

  • 1. Different vasodilating mechanisms--different peripheral effects?
    Breckenridge A; Roberts D; Walley T
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S23-6. PubMed ID: 1378145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive medications.
    Slagle MA
    South Med J; 2001 Nov; 94(11):1071-3. PubMed ID: 11780676
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasodilatory action of carvedilol.
    Sponer G; Strein K; Bartsch W; Müller-Beckmann B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal effects of antihypertensive medications: an overview.
    Abbott KC; Bakris G
    J Clin Pharmacol; 1993 May; 33(5):392-9. PubMed ID: 8101193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of drugs in countering adverse pathophysiological profiles: influence on hemodynamics.
    Lund-Johansen P
    Am Heart J; 1987 Oct; 114(4 Pt 2):958-64. PubMed ID: 2889344
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal consequences of antihypertensive therapy.
    Eknoyan G; Suki WN
    Semin Nephrol; 1991 Mar; 11(2):129-37. PubMed ID: 1674622
    [No Abstract]   [Full Text] [Related]  

  • 9. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK; Neuman SL
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronotherapeutic evaluation of the antihypertensive treatment].
    Lemmer B
    Rev Esp Cardiol; 1999; 52 Suppl 3():45-52. PubMed ID: 10614149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of antihypertensive drug therapy on arterial compliance.
    Resnick LM; Lester MH
    Am J Hypertens; 2002 Dec; 15(12):1096-100. PubMed ID: 12460707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum antihypertensive effect from different classes of antihypertensives.
    Koval PG; Kochis EM
    Arch Fam Med; 2000 Jun; 9(6):557-9. PubMed ID: 10862219
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interactions between antihypertensive drugs].
    Takagi M; Matsuoka H
    Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.